Introduction
Autophagy has been well recognized as a key intracellular degradation and recycling machinery for maintaining cellular homeostasis, whose dysregulation leads to cancer (1) . Beclin 1 (Becn1) acts as a core component of the class III phosphatidylinositol 3-kinase Vps34 complex, which is critical for the initiation of autophagy and autophagosome formation (2) . Becn1 was first described as a tumor suppressor, as monoallelic deletion of Becn1 results in spontaneous tumor formation (3) . However, given the complexity of the tumor microenvironment, which requires spatiotemporal interactions between tumor cells and other nontumor components, such as fibroblasts and stroma, endothelial, and myeloid cells, the cell type-specific roles of Becn1 in tumor development and immunity are still elusive. Neutrophils are an important component in cancer immunity (4) and regulate many other diseases, such as Alzheimer's disease (5) , through the release of cytokines IL-21 and IL-17 and neutrophil extracellular traps (NETs). For instance, neutrophils with B cell helper phenotype are correlated with tumor development (6) (7) (8) . However, the detailed mechanism that controls the neutrophil differentiation toward a protumorigenic B cell helper phenotype is undefined.
Cancer cells escape from T cell-mediated cytotoxicity by exploiting the inhibitory immune checkpoint molecules, including the receptor of programmed death 1 (PD-1) and its ligand PD-L1. Binding of PD-L1 to its receptor, PD-1, on activated T cells inhibits the T cell-activating signals and antitumor immunity (9) . Notably, B cell lymphomas also leverage the PD-L1/PD-1 checkpoint to induce immune escape (10) . PD-L1 expression in cancer cells is regulated by mechanisms that include aberrant oncogenic and inflammatory signaling and protein stability (9) . However, mechanisms regarding the recruitment of specific myeloid subsets to interact with cancer cells and drive the tumor development and immune evasion through immune checkpoint molecules are still elusive.
In this study, we show that neutrophil-derived inflammation is critical for mouse survival in LPS-induced septic shock and responsible for the high incidence (~25%) of spontaneous precursor B cell (pre-B cell) lymphoma development in mice with myeloid-specific ablation of Becn1. We further identify Becn1 as a neutrophil-specific negative regulator of the MEKK3/p38 signaling axis in an autophagy-independent manner, which is critical for (a) expression of B cell prosurvival factors IL-17, IL-21, and B cell-activating factor (BAFF); (b) interaction of neutrophils and B cells through CXCR3/CXCL9 chemotaxis; and (c) persistent activation of IL-21/STAT3-IRF1 and CD40L/ERK signaling in B cells that together regulate PD-L1 expression to suppress antitumor CD8 + T cell function. Consistently, by analyzing the human Beclin 1 (Becn1) is a key molecule in the autophagy pathway and has been implicated in cancer development. Due to the embryonic lethality of homozygous Becn1-deficient mice, the precise mechanisms and cell type-specific roles of Becn1 in regulating inflammation and cancer immunity remain elusive. Here, we report that myeloid-deficient Becn1 (Becn1 ΔM ) mice developed neutrophilia, were hypersusceptible to LPS-induced septic shock, and had a high risk of developing spontaneous precursor B cell (pre-B cell) lymphoma with elevated expression of immunosuppressive molecules programmed death ligand 1 (PD-L1) and IL-10. Becn1 deficiency resulted in the stabilization of MEKK3 and aberrant p38 activation in neutrophils, and mediated neutrophil-B cell interaction through Cxcl9/Cxcr3 chemotaxis. Neutrophil-B cell interplay further led to the activation of IL-21/STAT3/IRF1 and CD40L/ERK signaling and PD-L1 expression; therefore, it suppressed CD8 + T cell function. Ablation of p38 in Becn1 ΔM mice prevented neutrophil inflammation and B cell tumorigenesis. Importantly, the low expression of Becn1 in human neutrophils was significantly correlated with the PD-L1 levels in pre-B acute lymphoblastic lymphoma (ALL) patients. Our findings have identified myeloid Becn1 as a key regulator of cancer immunity and therapeutic target for pre-B cell lymphomas.
Myeloid loss of Beclin 1 promotes PD-L1 hi precursor B cell lymphoma development Becn1 negatively regulates p38 activation and inflammation in neutrophils. We next examined TLR-mediated innate immune signaling responses between WT and Becn1-deficient neutrophils and macrophages in the periphery of 6-to 8-week-old mice and found that p38 MAPK activity was increased, while inhibitor of NF-κB (IκB) kinase (IKK) activation was slightly reduced in neutrophils after LPS (a TLR4 ligand) or Pam3CSK4 (a TLR2 ligand) stimulation ( Figure 2 , A and B, and Supplemental Figure 2 , A and B). Becn1-deficient neutrophils produced a higher amount of TNF-α and IL-1β, but Becn1-deficient macrophages produced higher amounts of TNF-α and IL-6 ( Figure 2C ). Consistently, we observed an increase in the expression of pro-IL-1β in Becn1deficient neutrophils, but not in macrophages ( Figure 2D ). It has been shown that there was significant accumulation of neutrophils in the model of Listeria-infected SRB1 -/mice compared with WT mice, suggesting a critical role of SR-B1 in the differential regulation of neutrophils and macrophages (11) . However, no difference was observed in Scarb1 expression in Becn1-deficient neutrophils and macrophages with or without LPS treatment (Supplemental Figure 2C ). Therefore, the differential regulation of Becn1 in the activation of p38 and proinflammatory cytokine production is cell type specific, but independent of SR-B1.
Also, Becn1 expression was induced during M2 macrophage polarization by IL-4 or IL-10 (Supplemental Figure 2D ). Becn1deficient BM macrophages were readily differentiated into proinflammatory M1 macrophages by LPS (Supplemental Figure 2E ). To further define the physiological function of Becn1, we showed that Becn1 ΔM mice died after LPS-induced endotoxin shock (30 mg/kg) within 12 hours compared with WT mice, which survived for up to 40 hours ( Figure 2E ). Consistent with this observation, Becn1 ΔM mice had markedly elevated serum concentrations of proinflammatory cytokines such as TNF-α, IL-6, and IL-1β after LPS treatment ( Figure 2F ). Since ROS are closely linked to inflammation (12), we treated neutrophils and macrophages with LPS for 180 minutes and then incubated cells with CM-H2DCFDA for 30 minutes. Flow cytometry analysis revealed a modest increase of ROS production in Becn1-deficient neutrophils (Supplemental Figure 2F ). In contrast, ROS production was lower in Becn1-deficient macrophages than in WT cells after LPS stimulation (Supplemental Figure 2F ). To determine which cell type contributed to the susceptibility of Becn1 ΔM mice to LPS treatment, we depleted macrophages using clodronate-containing liposomes (13) and neutrophils using Ly6G antibody (IA8) (ref. 14 Figure 2G ). We found that macrophage depletion did not change mouse survival after LPS-induced septic shock. However, there was significantly prolonged survival in neutrophil-depleted mice ( Figure 2G ), indicating that neutrophils play a dominant role in LPS-induced septic shock. These results suggest that Becn1 deletion in myeloid cells enhances the sensitivity and severity of LPS-induced septic shock, probably through the increased serum concentrations of proinflammatory cytokines.
and Supplemental
To determine the role of Becn1 in regulating innate immune signaling and gene expression in neutrophils, we performed RNA-Seq analysis of freshly isolated neutrophils after 4 hours of LPS treatment. Interestingly, we observed marked upregulation of genes involved in pathways related to inflammation, rheumatoid arthritis, and inflammatory bowel diseases (Figure pre-B cell acute lymphoblastic lymphoma (ALL) patient samples, we reveal that the low expression of Becn1 in tumor-infiltrated neutrophils correlates with tumor PD-L1 expression, and similar positive correlations are also observed between any 2 of the following 3 factors: neutrophil marker, IL-21, and PD-L1. Together, our findings identify myeloid Becn1 as a non-cell-autonomous tumor suppressor in the regulation of pre-B cell malignancy and immunosuppressive function.
Results
Myeloid-specific ablation of Becn1 induces splenomegaly and lymphadenopathy with neutrophilia. To investigate the role of Becn1 in myeloid lineage development and innate immune response, we crossed Becn1 fl mice with mice expressing the lysozyme promoterdriven Cre recombinase gene (Lyz2-Cre), designated as Becn1 ΔM mice. Cohoused littermate Becn1 WT or Becn1 flox ;Lyz2-Cremice were used as WT controls. Conditional Becn1 deletions in F4/80 + CD11b + peritoneal macrophages (pMAC) and Ly6G + CD11b + neutrophils were verified by immunoblot analyses compared with CD11c + conventional DCs (cDCs), CD4 + T cells, and CD19 + B cells (Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/JCI127721DS1). Notably, Becn1 ΔM mice developed splenomegaly and had profound enlargements on inguinal, axillary, and mesenteric LNs ( Figure 1 , A and B). Spleen (SP) mass and the total number of splenocytes were markedly increased ( Figure 1A and Supplemental Figure 1B ). Histological analysis of SP sections revealed a marked effacement of the splenic architecture, with loss of marginal zone (MZ) barriers and a concomitant loss of the clear-cut delimitation between the lymphoid and myeloid parenchyma ( Figure 1A ). Hematologic analysis of peripheral blood in Becn1 ΔM mice showed increased circulating neutrophils, white blood cells, and eosinophils, but decreased platelets (Supplemental Table 1 ). Consistently, expanded Ly6G + splenic neutrophils with normal shape and segmentation accumulated in the red pulp of SP surrounding MZ B cells (Supplemental Figure 1C ).
Loss of myeloid-specific Becn1 markedly increased the number of Gr-1 + CD11b + myeloid-lineage cells, which is mainly contributed to by the increase of Ly6G + CD11b + neutrophils in the BM and SP. However, the percentages of F4/80 + CD11b + macrophages and CD11b + Ly6C + monocytic cells remained unchanged (Figure 1 , C-G). Besides, we found an increase in total SP B220 + B cells in some of the Becn1 ΔM mice ( Figure 1C ), but not B220 + CD-11c + CD11bplasmacytoid DCs (pDCs) (Supplemental Figure 1D ). There was no significant difference in the percentages of different CD4 + T cell subsets and T cell functions for cytokine release (Supplemental Figure 1 , E and F). Gr-1 + CD11b + cells and F4/80 + CD11b + cells also showed equal levels of apoptosis (Supplemental Figure  1G ). We further transplanted a 1:1 mixture of CD45.1 + WT and Becn1 ΔM CD45.2 + BMs into lethally irradiated CD45.1 + WT mice, in which Becn1 ΔM CD45.2 + BM cells showed a growth advantage (Supplemental Figure 1H ). The neutrophil counts of mice reconstituted with Becn1 ΔM CD45.2 + BM cells were approximately 4-fold higher than those that received CD45.2 + WT BM (Supplemental Figure  1I ). Together, our results suggest that neutrophilia in Becn1 ΔM mice is driven by factors intrinsic to hematopoietic cells, causing accelerated proliferation and/or enhanced survival of neutrophil progenitors or mature neutrophils. jci.org Volume 129 Number 12 December 2019 es p38 activation and produces large amounts of IL-1β, TNF-α, IL-17, and IL-21 in neutrophils.
Autophagy-independent degradation of MEKK3 by Becn1 suppresses p38 signaling. Since NF-κB and MAPK pathways trigger the downstream signaling of IKK complex, Erk1/2, p38, and JNK through the activation of MAP3Ks (TAK1, ASK1, MEKK3) (18), we tested to determine whether Becn1 interacted with these key signaling molecules and observed strong interaction of Becn1 with MEKK3 and MKK3, only weak interaction with IKKβ and NEMO, 2H, Supplemental Figure 2H , and Supplemental Table 2 ). The key candidates included genes encoding IL-17 and related cytokines, chemokine receptor and chemotaxis, cell metabolism, and immunity. Neutrophils are another source of IL-17 besides Th17 cells (5, (15) (16) (17) . We next isolated Becn1-deficient neutrophils and pMACs, treated them with LPS, and found significantly higher levels of IL-17A and IL-21 in Becn1-deficient neutrophils compared with WT controls or macrophages (Supplemental Figure  2I ). Together, our results suggest that Becn1 deletion enhanc- that Becn1 regulates MEKK3 stability and MEKK3/p38 signaling activation in neutrophils.
To understand how Becn1 regulates MEKK3 for degradation, we showed that proteasome inhibitor MG132, but not autophagy inhibitors 3-methyladenine (3-MA) or chloroquine (CQ), blocked Becn1-mediated MEKK3 degradation ( Figure 3G ), suggesting that Becn1 degrades MEKK3 through a proteasome-dependent manner. Protein lysine (K) 48-linked ubiquitination has emerged as an and no interaction with IKKα, ASK1, TAK1, or p38 ( Figure 3 , A and B). Importantly, we found that MEKK3 protein was markedly reduced with an increasing amount of Becn1 in 293T cells ( Figure  3C ). Consistently, we found that the endogenous level of MEKK3 was markedly increased in Becn1-deficient neutrophils, but not macrophages ( Figure 3 , D and E). In addition, Becn1 deficiency increased the activation of MKK3/6, the MEKK3-downstream mediator for p38 activation ( Figure 3F ). These results suggest phenotypes and survival in response to LPS-induced septic shock of Becn1 ΔM mice, we generated Mapk14 fl/fl :Becn1 fl/fl :Lyz2-Cre double-KO (DKO) (Becn1 ΔM :Mapk14 ΔM ) mice. Gross phenotypic analysis revealed reduced SP size of Becn1 ΔM :Mapk14 ΔM that was comparable to that of WT SP ( Figure 4A ). Consistently, the percentages (41.4% in BM, 14.5% in SP) of CD11b + Gr-1 + cells in Becn1 ΔM mice were reduced to 22.2% in BM and 7.26% in SP in Becn1 ΔM :Mapk14 ΔM mice, which were similar to the levels in WT mice ( Figure 4B ). The serum levels of TNF-α, IL-1β, and IL-17 cytokines in Becn1 ΔM : Mapk14 ΔM mice were also reduced to levels similar to those of WT controls, even though IL-6 production remained at a relatively important mechanism for targeting a protein for proteasomal degradation (19) . To identify key lysine residues in MEKK3 required for K48-linked ubiquitination, we substituted a series of lysine residues with arginine and found that lysine 299 (K299) residue was essential in Becn1-mediated MEKK3 ubiquitination and proteasome degradation ( Figure 3 , H and I). These results suggest that Becn1 targets MEKK3 for ubiquitination-dependent proteasomal degradation through the K299 residue in MEKK3. Genetic ablation of p38 or MEKK3 rescues Becn1 ΔM mouse phenotypes. To determine whether specific deletion of p38 (encoded by Mapk14) or MEKK3 (encoded by Map3k3) could rescue the higher level in both Becn1 ΔM :Mapk14 ΔM and Becn1 ΔM mice ( Figure  4C ). Importantly, p38 ablation in Becn1 ΔM prolonged the survival to a level similar to that of WT mice in response to LPS-induced septic shock, but IL-6 ablation in Becn1 ΔM mice failed to do so ( Figure  4D ), suggesting that TNF-α and IL-1β, but not IL-6, are responsible for sensitivity to LPS-induced septic shock. Because mouse Becn1 and Map3k3 are on the same chromosome (mm11, NC_000077.6), it is difficult to generate Map3k3 fl/fl : Becn1 fl/fl :Lyz2-Cre DKO mice. For this reason, we used a CRISPR-Cas9 genome editing approach (where CRISPR indicates clustered regularly interspaced short palindromic repeats) (20) to generate Becn1 ΔM :Map3k3 Cas9 BM chimera. BM chimera with WT BM or Becn1 ΔM BM transduced with nontargeting control sgRNA were used as WT or Becn1 ΔM single-KO controls. The LPS-induced phosphorylation of p38 in neutrophils isolated from Becn1 ΔM :Map-3k3 Cas9 mice was significantly reduced ( Figure 4E ). In addition, neutrophil number and serum levels of proinflammatory cytokines TNF-α, IL-1β, and IL-17 in Becn1 ΔM :Map3k3 Cas9 mice were restored to WT chimeric control ( Figure 4 , F and G). Consistently, Becn1 ΔM :Map3k3 Cas9 mice were more resistant to LPS when compared with the Becn1 ΔM group ( Figure 4H ). These results indicate that p38 or MEKK3 ablation in neutrophils restores inflammatory cytokine (TNF-α, IL-1β, and IL-17) production and reduces hypersensitivity to LPS-induced septic shock observed in Becn1 ΔM mice.
Spontaneous development of metastatic pre-B cell lymphoma in Becn1 ΔM mice. During this work, we unexpectedly observed the occurrence of highly proliferative lymphoma in the cervical LNs in 40% of Becn1 ΔM mice ( Figure 5 , A and B), with accumulating infiltration of tumor cells in other tissues, such as lungs, heart, and thymus (Supplemental Figure 3A) . H&E staining of the infiltrated tumor cells revealed that the medium-size tumor cells contained centrally located and prominent nucleoli (Supplemental Figure  3A ), suggesting a pre-B cell lymphoblastic lymphoma phenotype (21) . These tumor cells were positive for B220 staining, but negative for monocyte (Mac-3), macrophage (Mac-1), neutrophil (Ly6G), or T cell (CD3) markers ( Figure 5C , and Supplemental Figure 3 , B-D). The B cell origination of these tumor cells was further confirmed by PAX5 staining in lung infiltrates. Of note, lung-infiltrated tumor cells contained a majority of PAX5 + B220 lo/cells, but also PAX5 + B220 + populations ( Figure 5D ), when using low B220 antibody concentration (T1, 1:500 dilution, vs. high concentration [T2], 1:50 dilution), suggesting the heterogeneity of tumor cells. Unlike the B cell lymphoma in Becn1 +/mice that expresses BCL-6 protein (3), we found that the LN or lung-infiltrated B220 + tumor cells in Becn1 ΔM mice were negative for BCL-6 ( Figure 5E ).
Using CFSE labeling, we showed that B cells isolated from Becn1 ΔM tumor-bearing mice were more proliferative than WT B cells after treatment with LPS and IL-4 ( Figure 5F ). Malignant B cells from Becn1 ΔM tumor-bearing mice also displayed a unique phenotype, with increased expressions of B cell surface markers, including CD16/32 (FcΥRIII/FcΥRIIa), activation markers (CD80, CD86), and MHC class I ( Figure 5G ). Importantly, the elevated percentages of pre-B cells expressed low/intermediate B220 (16. Figure 3E ). We found a small population of autoreactive CD3 + B220 + double-positive cells proliferated in Becn1 ΔM mice, as an autoimmunity-prone phenotype observed in Fas-mutant lpr/ lpr lupus mice (ref. 22 and Figure 5H ). Consistently, Giemsa staining of BM cells showed a significant loss of lymphocytes, with dark nucleus staining and an increased number of granulocytes (Supplemental Figure 3F) . Further, the cell-cell junction in bone sections of Becn1 ΔM mice was not as tight as in WT mice, as evident from H&E staining (Supplemental Figure 3F ). Since sphingosine-1-phosphate receptor (S1P1R) or CXCR4 controls B cell BM egression or retention (23, 24) , respectively, we sorted B cells from both WT and Becn1 ΔM mice and found a marked reduction of CXCR4 expression, but not S1P1R, in B cells from Becn1 ΔM mice ( Figure 5L ), which might contribute to the pre-B cell BM egression.
Becn1-deficient neutrophils interact with B cells in tumor sites. By using immunohistochemical (IHC) staining and immunofluorescence (IF), we observed the colocalization of B cells with a large number of neutrophils in the tumor sites, lungs, and intestinal Peyer's patches (with a strip of neutrophils surrounding B cell zone) ( Figure 6 , A-C, and Supplemental Figure 4A ). To determine the gene expression profiling (GEP) of the tumor and a potential role of neutrophils in tumor development, we extracted total RNA from cervical LN tumors for RNA-Seq and found many overexpressed genes in Becn1 ΔM mice, including those encoding inflammatory and B cell-stimulating molecules (Nos2, Ptgs2, Il21, Il1b, Il12, Tnfsf13b, Tnfsf18, Nlrp3), chemoattractants (Cxcl9, Cxcr3), neutrophil marker (Ly6g), and critical mediators of apoptotic cell removal (Supplemental Figure 4 , B-E, and Supplemental Table 3 ). Transcriptional factors Ebf1 and Pax5, which have been reported to essentially contribute to the expansion of B cell progenitors and acute lymphoid leukemia transformation (25) , were also upregulated (Supplemental Figure 4F ). Notably, the downregulated genes included cell junction molecules related to leukocyte transendothelial migration (Cdh1, Cldn, Tjp1) (Supplemental Figure  4 , B and G), which might permit the noncanonical interactions between B cells and activated myeloid cells.
Neutrophils have been illustrated as acquiring a B cell helper phenotype to promote B cell expansion and malignancy through several different mechanisms, including (a) contact-independent cytokine secretion, such as Tnfsf13b and IL-21, and (b) contactdependent mechanisms, such as CD40 and NETs (6, 7) . Except for MCL-1 and BCL-2, marked upregulation of B cell helper signature genes was observed in Becn1-deficient neutrophils from tumor-bearing mice ( Figure 6 , D and E).
Furthermore, we found an increased accumulation of Ly6G + neutrophils in the tumor (LN and lung infiltrates) with autoactivation of p38, which might contribute to IL-21 production ( Figure  6F ). Since myeloid-derived suppressor cells (MDSCs) expressed Gr-1 (Ly6C and/or Ly6G) and CD11b molecules are known to dampen immune response by inhibiting CD4 + and CD8 + T lymphocyte function in cancer, we tested to determine whether the accumulation of Ly6G + CD11b + cells in Becn1 ΔM mice has a suppressive function. The T cell proliferation assay (determined by the incorporation of [ 3 H] thymidine) showed that neutrophils (Ly6G + ) isolated from Becn1 ΔM mice (either with or without B cell lymphoma) had no significant suppressive effect on T cell proliferation (Supplemental Figure 4, H Staining of Becn1-deficient neutrophils derived from tumorbearing mice with SYTOX impermeable DNA dye revealed an increased projection of NETs ( Figure 6G) . Thus, the recruitment of neutrophils by B cells through Cxcl9/Cxcr3 chemotaxis ( Figure  2H stand the signaling pathways in B cells that control the expression of PD-L1, we applied MAPK inhibitors (p38i, SB 203580; ERKi, U0126; JNKi, sp 600125), NF-κB inhibitor (BAY 11-7082), and STAT3 inhibitor (STAT3i, WP 1066) to sorted B cells after coculture with Becn1-deficient neutrophils. The inhibition of ERK and STAT3 was able to reduce the PD-L1 level, suggesting that both ERK and STAT3 signaling pathways are involved in the regulation of PD-L1 expression (Supplemental Figure 5F ). We also detected the upregulation of IRF1 in B cells (Figure 7, A and B) . IRF1 is an essential transcription factor that regulates PD-L1 and MHC-I expression (31, 32) . In addition, ERK signaling promotes PD-L1 expression through the negative regulation of tristetraprolin (TTP, encoded by Zfp36) expression and activity, which is a zinc-finger RNA-binding protein that suppresses PD-L1 mRNA through binding to the AU-rich element at 3′ UTR (33) . By inhibition of STAT3 and ERK signaling, we observed reduced levels of Irf1 (by STAT3i) and increased levels of Zfp36 (by ERKi) (Supplemental Figure  5G ), suggesting that the activations of both ERK/TTP and STAT3/ IRF1 signaling by neutrophil-derived factors contributed to the upregulation of PD-L1 expression in pre-B cell lymphoma cells. Notably, no change was observed in the expression of Cmtm4/6, which stabilize the PD-L1 protein (34) , in B cells after coculture with Becn1-deficient neutrophils (Supplemental Figure 5H) .
To further demonstrate the effects of neutrophil factors that promote PD-L1 expression in vivo, we treated Becn1 ΔM mice (6 to 8 weeks old without tumors) by i.p. injection of recombinant neutrophil factors (Supplemental Figure 6A ) and found that IL-21 significantly promoted the enlargement of cervical LN as well as PD-L1 expression in sorted CD19 + or B220 + B cells (Supplemental Figure  6B) . In contrast, irradiated Becn1 ΔM mice reconstituted with BM from tumor-bearing Becn1 ΔM mice with IL-21 ablation (Becn1 ΔM: Il21 KO) showed a reduction of PD-L1 expression and STAT3 activation (Figure 7 , F and G). To further examine the physiological role of PD-L1 molecules in cancerous pre-B cells in the regulation of the endogenous antilymphoma CD8 + T cells, we injected Becn1 ΔM tumor-bearing mice with antibodies against PD-L1 or IL-21R, compared them with mice injected with IgG control, and found a significantly increased number of total CD8 + cells as well as CD8 + IFN-γ + and CD8 + Granzyme B + T cells in the tumor region (Supplemental Figure 6 , C and D).
Since p38 signaling regulated neutrophil inflammation in Becn1 ΔM mice in response to TLR ligand stimulation (Figures 2 and  4) , which was autoactivated in tumor-derived neutrophils ( Figure  6F Table 4 ).
We next sought to determine whether the tumor cells had altered oncogenic signaling, as suggested in previous studies (28, 29) . The tumor and control cells were sorted by B220-positive selection, followed by immediate lysis or anti-CD40 agonist stimulation. We observed elevated activations of ERK and JNK; downstream signaling of IL-21 (p-STAT1, p-STAT3, p-STAT5, with total STAT3 unchanged); and BAFF (noncanonical NF-κB p52); as well as upregulated STAT5-target (antiapoptotic gene MCL-1) (ref. 30 and Figure 7C and Supplemental Figure 5A) . A recent study demonstrates that hyperactivation of AKT by PTEN ablation triggers the death of pre-B cells (26) . However, we did not observe the changes of AKT and FOXO1 phosphorylation in these B cells (Supplemental Figure 5A ). Consistent with the upregulation of MCL-1, we observed reduced apoptosis of B cells isolated from the tumor, but not the non-tumor bearing Figure 5B ). Moreover, we compared the signaling activations in B cells from WT, tumor-free Becn1 ΔM (NT), and B220 hi versus B220 lo cells from tumor-bearing Becn1 ΔM mice and found that B220 lo cells had higher levels of phosphorylated STAT1/3/5 and PD-L1 than B220 hi cells (Figure 7 , D and E). By coculturing the neutrophils or macrophages from tumor-bearing Becn1 ΔM mice with normal WT B cells, we found the induction of PD-L1, as well as CXCR3 ligands Cxcl9/10, in B cells by neutrophil-derived factors (Supplemental Figure 5, C and D) . Further, the upregulation of PD-L1 could be abolished by antibody blockade of either IL-21 or CD40L (Supplemental Figure 5E) . To under- we found lower Becn1 expression in neutrophils among human pre-B cell ALL patients compared with normal controls ( Figure  7H) . Notably, in recurrent pre-B cell ALL patients, neutrophils with low Becn1 expression had a NET-like structure ( Figure 7H) . significantly among the different B cell lymphoid malignancies, with the lowest levels in pre-B cell ALL and the highest in mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) (Supplemental Figure 6I and Supplemental Table 5 ). Furthermore, mation from nontransformed immune cells in the tumor microenvironment. While Becn1 expression is intact in pre-B cells, Becn1 ΔM mice showed a high risk of TdT + pre-B cell lymphoma formation (40% frequency) as early as the age of 15-25 weeks. The accumulation of neutrophils, but not macrophages, was found to colocalize and interact with malignant B cells in tumor sites. It is worth noting that neutrophilia developed in mice with or without lymphoma, probably due to p38 activation and high levels of IL-1β, which could cause the accumulation of neutrophils through IL-1R1 signaling (42) . Although Becn1 deficiency in myeloid cells did not alter the number and overall infiltration of macrophages, these macrophages are prone to display M1 phenotypes known to be antitumor (43) . Furthermore, we found that the pre-B tumor cells were egressed from BM. It has been reported that stromal cells, Bruton's tyrosine kinase, the S1P/S1P receptor, CXCL12/CXCR4 signaling cascades, and α4β1-VCAM-1-mediated adhesion could all regulate the B cell migration from BM (7, (44) (45) (46) (47) . Our data suggest that the BM (a major pool of myeloid cells, such as neutrophils) is a critical location for pre-B cells to be activated by local inflammatory neutrophils in tumor-bearing Becn1 ΔM mice. This unique interaction led to the egression of pre-B (B220 lo ) cells from BM (by downregulation of BM retention signal Cxcr4, but not the S1P egression signal), serving as a prerequisite step for the development of metastatic pre-B cell lymphoma in cervical LNs and lungs. We reason that the IL-21 produced by tumor-associated neutrophils and subsequent STAT3/SOCS3 activation in B cells are the potential mechanisms to control the lodgment of pre-B cells in the BM, as it could downregulate CXCR4 signaling (48, 49) . Recent studies also identify a unique population of IL-21secreting neutrophils, termed B cell helper neutrophils, to sustain B cell survival, expansion, and malignant transformation (7, 8) . IL-21 receptor signaling has been linked to inflammation and autoimmune diseases, such as SLE (50) . IL-21 also enhances inflammation-associated malignancy (51) . However, the potential mechanisms underlying the differentiation and transition of neutrophils to gain "B cell helper" function remain unknown. In this study, we showed that Becn1 is a key regulator governing the transition of normal neutrophils into protumoric neutrophils with upregulated B helper signatures, including IL-21, BAFF, CD40L, and the production of NET. These factors have been shown to activate multiple oncogenic signaling pathways, such as STATs and noncanonical NF-κB, that are crucial in initiating oncogene transcription and establishing the tumor premetastatic niche (29, (52) (53) (54) . Therefore, myeloid deficiency of Becn1 provides a unique model for investigating the neutrophil/B cell interaction.
Strikingly, when comparing B220 lo with B220 hi cell populations, we showed that B220 lo cells had higher and persistently activated STAT1, STAT3, STAT5, and noncanonical NF-κB p52, followed by the upregulation of their downstream targets MCL-1, chemokine Cxcl9, and checkpoint inhibitor PD-L1. The interaction with Becn1-deficient neutrophils also activated B220 hi cells in tumor sites, but to a lesser extent, compared with B220 lo cells, suggesting the heterogeneity of these tumor cells. We also demonstrated that CD40L/ERK and IL-21/STAT3-IRF1 were key signaling pathways for governing the expression of PD-L1 in pre-B cells. IL-21 treatment in Becn1 ΔM mice promoted lymphoma formation in cervical LN and PD-L1 expression on B cells. These findings are Consistent with the upregulation of PD-L1 in B cells from Becn1 ΔM mice, we found upregulation of PD-L1 in pre-B cell ALL patient BM and LN samples, especially in recurrent pre-B cell ALL samples ( Figure 7I ). In a clinical study of B-cell ALL patients (Therapeutically Applicable Research to Generate Effective Treatment [TARGET] ALL projects), significant positive correlations were observed in the expression of IL-21, PD-L1 (CD274), and neutrophil markers (human ortholog LY6G6D and CD177) (refs. 35, 36, Figure 7J , and Supplemental Figure 6J ). These data suggest that low Becn1 expression in neutrophils might have a direct link to PD-L1 level expression and recurrence in human pre-B cell ALL. Thus, our results suggest that the low Becn1 expression in neutrophils correlates with PD-L1 levels in pre-B cell ALL patients.
Discussion
Despite the importance of autophagy in macrophages during Mycobacterium tuberculosis infection or LC3-associated phagocytosis (37, 38) , little is known about the in vivo function of Becn1 in neutrophils regarding inflammation and cancer immunity. Our study showed that deletion of Becn1 in the myeloid lineage led to neutrophilia, which caused splenomegaly and lymphadenopathy in mice. We uncovered a cell type-specific mechanism of Becn1 as a negative regulator of p38 signaling in neutrophils. Depletion of neutrophils, but not macrophages, could rescue the sensitivity of Becn1 ΔM mice to LPS endotoxin shock, suggesting excessive LPSinduced neutrophil inflammation. Our cytokine profiling and RNA-Seq analyses further revealed the enhanced production of TNF-α, IL-1β, ROS, IL-17-related cytokines, and chemokine-receptor CXCR3 by neutrophils in Becn1 ΔM mice. p38 MAPK signaling is critical for the transcription and production of inflammatory cytokines (39, 40) . Consistent with the cell-depletion results, we provided compelling genetic evidence that p38 (encoded by Mapk14) ablation in myeloid cells rescued the observed phenotypes and the production of inflammatory cytokines in Becn1 ΔM mice. NF-κB activation is known to negatively regulate IL-1β secretion in neutrophils in myeloid IKKβ-deficient mice (41) . Consistently, we observed reduced IKK phosphorylation and increased IL-1β secretion upon LPS stimulation in Becn1-deficient neutrophils. Despite the elevated production of IL-6 in macrophages, IL-6 ablation failed to rescue the survival of Becn1 ΔM mice from LPS-induced septic shock.
It is known that MAP3K (TAK1, ASK1, MEKK3) activation triggers downstream signaling of IKK complex, Erk1/2, p38, and JNK (18) . We showed that Becn1 interacted with MEKK3 and MKK3 and promoted the MEKK3 K48 ubiquitination at K299 and subsequent autophagy-independent proteasomal degradation. Due to the low protein level of MEKK3 observed in neutrophils, the activation of p38 in neutrophils is mainly triggered by upstream molecules other than MEKK3, such as TAK1. The stabilization of MEKK3 upon Becn1 deletion thus leads to aberrant activation of neutrophils through the MEKK3/MKK3/p38 signaling axis. Consistently, further ablation of MEKK3 significantly prolonged the survival of Becn1 ΔM mice from LPS-induced septic shock.
Heterozygous deletion of Becn1 increases the incidence of spontaneous tumors in mice, including diffused large cell B cell lymphoma (DLBCL) (3), suggesting that Becn1 is a haploinsufficient tumor suppressor. However, it is unclear whether the tumor formation is induced by intrinsic factors or by oncogenic inflam-
Methods
Animals and in vivo procedures. Adult C57BL/6 (CD45.2) and Boy/J (CD45.1) mice were obtained from the Jackson Laboratory. Becn1 fl mice (Knockout Mouse Project [KOMP] Repository) were crossed with lysozyme-Cre (Lyz2-Cre) mice (Jackson Laboratory) to obtain Becn1 ΔM mice on the C57BL/6 background. Mouse genotyping primers to detect WT and flox/flox mutant were as follows: Becn1-1R: 5′-GCG-GATCCCTGAGTTCTAGACTAACC-3′; Becn1-1F (ttR): CTCCCAAT-GCTGGGATTAAAGACG-3′; and Becn1-2R (F): TTGTACCGT-GATTTAGGGCGTTTGC-3′. Becn1 ΔM mice were bred with Mapk14 fl mice (provided by Y. Wang, UCLA, Los Angeles, California, USA,and H. Jiang, Boehringer-Ingelheim) or Il6 -/mice (Jackson Laboratory) to generate Becn1 ΔM :Mapk14 ΔM and Becn1 ΔM :Il6 -/mice, respectively. To generate Becn1 and Map3k3, Becn1 and Il21 DKO BM chimeric mice, deletions of Map3k3 and Il21 were achieved by a CRISPR-Cas9 system (20) . We used the following sgRNA sequences to target exon1 of Map3k3: ACCGGGTTCGTCGGCTCATC and exon1 of Il21: Il21sg-RNA-1 GGTGACGAAGTCTAATCAGG and Il21-sg-RNA-2 GCT-GTTCAACAATGTCAATA. Scrambled mouse sgRNA served as control: GCGAGGTATTCGGCTCCGCG. Total BM was isolated from the femur and tibia of 6-to 10-week-old female C57BL/6 WT mice or Becn1 ΔM mice. BM was subjected to erythrocyte lysis (BD PharmLyse, BD Biosciences), followed by magnetic bead selection of cKit-positive cells using CD117 MicroBeads (Miltenyi Biotec). Prior to flow sorting using BD FACSAria II, CD117-selected cells were stained with APC-labeled cKit (eBioscience), PE-labeled Sca1 (BioLegend), Pacific blue-labeled Gr1, CD11b, B220 (CD45R), Ter119, and CD3 (eBiosciences). LSK cells were cultured in StemPro-34 SFM complete medium (Thermo Fisher) supplemented with 50 ng/mL murine Thpo and 50 ng murine Scf (Life Technologies) for 48 hours and then transduced with concentrated lentiviral supernatant in the presence of 2 μg/mL polybrene. At 24 hours after transduction, cells were collected and i.v. injected into lethally irradiated (950 cGy) 6-to 10-week-old female C57BL/6 mice (Jackson Laboratory). Since the CRISPR-Cas9 genotyping data provided only a "snapshot" of the polyclonal cell population genotype, the possibility that not all alleles had been targeted by this approach could not be ruled out. For BM chimeras, approximately 1.5 × 10 6 total BM cells from CD45.1 + donors (see Supplemental Table  7 ) were mixed with 1.5 × 10 6 total BM cells from adult WT (CD45.2 + ) or Becn1 ΔM (CD45.2 + ) mice and then were transferred into adult WT CD45.1 + mice that had been exposed to 950 cGy. Chimeras were analyzed at least 6 weeks after reconstitution. To study in vivo endotoxicity, mice received i.p. injections of LPS (25-30 mg/kg) and blood samples were collected to assay plasma cytokine concentrations.
RNA-Seq. Total RNA was used for mRNA isolation and cDNA library generation with the miRNeasy Micro Kit (QIAGEN). On-column DNase digestion (DNase-Free DNase Set, QIAGEN) was performed according to manufacturer protocols to prevent genomic DNA contamination. RNA and library preparation integrity were verified using a 2100 BioAnalyzer system (Agilent). Ribosomal RNA depletion was performed following the low-input protocol of RiboMinus Eukaryote System, version 2 (Thermo Fisher), with 500 ng total RNA input. Finally, libraries were prepared using the Ion Total RNA-Seq Kit, version 2 consistent with the previous report that cytokine IL-21 induces PD-L1 expression in CD19 + B cells, but not in purified T cells (55) . Based on these findings, we propose the feed-forward recruitment of neutrophils by pre-B cells via the CXCL9-CXCR3 chemotaxis to promote the development of immunosuppressive pre-B cell lymphoma. Notably, cGAS acts as a tumor enhancer in the presence of genotoxic or ROS stress through inhibiting homologous recombination-mediated DNA repair. Aberrant upregulation of cGAS transcripts has been reported in non-small cell lung carcinomas (27) . Similarly, we showed that cGAS mRNA levels were upregulated in pre-B tumor cells. The potential association between the upregulation of cGAS in pre-B tumor cells and the malignant transformation of pre-B cells awaits further investigation.
PD-L1 is one of the critical checkpoint inhibitory signaling molecules utilized by tumor cells or other immune suppressor cells to inhibit T cell function for immune evasion (56) . PD-L1-expressing IgA + B cells have been shown to suppress CD8 + T cells to kill liver tumor in a mouse model of inflammation-induced liver cancer (57) . Administration of PD-L1 or IL-21R antibody in Becn1 ΔM tumor-bearing mice reversed the suppressive function of immunosuppressive PD-L1 hi pre-B cells against CD8 + T cells. Injection of IL-21 increased the risk of developing lymphoma with upregulated PD-L1 in Becn1 ΔM mice, suggesting the critical role of IL-21 in tumor immunity. Importantly, low Becn1 expression in tumor-infiltrated neutrophils correlates with PD-L1 levels in recurrent pre-B ALL patients. In addition, positive correlations between any 2 of the following 3 factors were observed in pre-B ALL patients: neutrophil marker Ly6g, IL-21, and PD-L1, which recapitulates the malignant pre-B cells identified in Becn1 ΔM mice. Together, these findings indicate the potential of immunotherapy for the treatment of metastatic and/or recurrent pre-B ALL that acts by combining PD-L1 or IL-21 antibody blockade with inhibitors targeting tumor-infiltrating neutrophils. We also offer evidence to support the critical role of neutrophil-mediated inflammation in B cell migration and lymphomagenesis. Overall, our results provide molecular insights into the mechanisms of how Becn1-deficient neutrophils produce proinflammatory cytokines through regulation of p38 and MEKK3 Mouse Neutrophil Enrichment Kit (Stem Cell Technologies) to remove nonneutrophil populations. Tissue-infiltrated neutrophils were purified from intraparenchymal pulmonary or LN cell suspensions using an isolation method similar to that used for peritoneal neutrophils. Briefly, for lung neutrophil isolation, the chest of the mouse was opened, and the lung vascular bed was flushed with 2-3 ml of prechilled PBS injected into the right ventricle. Lungs were excised to avoid the paratracheal LNs and thymus and washed twice in RPMI 1640 media supplemented with penicillin/streptomycin. The excised lungs were minced finely, and the tissue pieces were placed in RPMI 1640 medium containing 2% FBS, 20 U/mL collagenase, and 1 g/mL DNase. Following incubation for 60 minutes at 37°C, any remaining intact tissue was disrupted by passage through a 21-gauge needle. Tissue fragments and the majority of dead cells were removed by rapid filtration through a glass-wool column, and cells were collected by centrifugation for 5 minutes at 500 g. Cells were subjected to enrichment using the EasySep Mouse Neutrophil Enrichment Kit. Immunoprecipitation and immunoblot analyses. For immunoprecipitation, whole-cell lysates were incubated overnight with indicated antibodies plus protein A and G beads (Pierce). For immunoprecipitation with anti-FLAG, anti-FLAG agarose gels were used. Beads were then washed 5 times with low-salt lysis buffer (50 mM HEPES, 15 mM NaCl, 1 mM EDTA, 1.5 mM MgCl 2 , 10% glycerol, 1% Triton X-100), and immunoprecipitates were eluted with ×4 SDS loading buffer. Immunoblotting was performed by resolving protein lysates on SDS-PAGE gels, followed by transfer to nitrocellulose membranes (Bio-Rad) and further incubation of membranes with indicated antibodies overnight (see Supplemental Table 7 ). For all blots, EMD Millipore Luminata Western HRP Chemiluminescence Substrate was used for protein detection (see complete unedited blots in the supplemental material).
Flow cytometry. Single-cell suspensions were obtained from tissues and stained for 30 minutes with indicated antibodies. For intracellular staining, CD4 + or CD8 + T cells were stimulated with PMA (15 nM) and ionomycin (0.5 μM) for 6 hours at 37°C in the presence of GolgiStop (monensin) (BD Biosciences -Pharmingen). Cells were then stained with the surface marker (see Supplemental Table 7 ) for 15 minutes on ice and permeabilized using Cytofix/Cytoperm (BD Biosciences) for 30 minutes on ice. Permeabilized cells were resuspended in BD Perm/ Wash buffer (BD Biosciences) and stained with cytokine antibody for 20 minutes. FACS analysis was performed with BD LSRII Flow Cytometer (BD), and data were analyzed by BD FACSDiva software.
Cytokine release assay. Cell supernatants or sera were collected at indicated time points after stimulation with LPS with or without ATP. Cytokine concentrations were determined by ELISA with TNF-α, IL-6, IL-1β, IL-17A, IL-17F, IL-21, IL-22, and BAFF antibodies (see Supplemental Table 7 ). ELISAs were performed according to the manufacturer's instructions. In brief, 96-well plates were precoated with the capture antibody (1:500 in coating buffer) at 4°C overnight. On the next day, the plate was washed with PBS/0.1%Tween 20 and blocked with 1%BSA/PBS diluent buffer for 2 hours at RT. Diluted supernatants and cytokine standards were then applied to the plate and incubated for 2 hours at RT. The plate was then washed and incubated with biotin-conjugated detection antibody (1:1000 in 1%BSA/PBS diluent buffer) for 1 hour at RT. The plate was then washed and incubated with poly-HRP streptavidin (1:5000 in the diluent buffer, Thermo Scientific) for 30 minutes. The plate was washed again and finally incubated with the tetramethylbenzidine substrate solution (Sigma-Aldrich). The reaction (Thermo Fisher), with minor changes to the standard protocol. These included lower amplification cycles and the usage of entire fragmented RNA for cDNA synthesis. For the sequencing reactions, an Ion Torrent Proton platform with V3 chemistry (Ion PI Template OT2 200 Kit, version 3, Thermo Fisher) and PIV2 Chips (Ion PI Chip Kit, version 2, Thermo Fisher) were used. The experiment was performed on 2 chips containing 2 biological replicates per condition (wt1/mt1 on chip A and wt2/mt2 on chip B), resulting in 163 million total reads and at least 40 million reads per library. Base calling was performed on Ion Torrent suite software. Raw sequencing reads in FASTQ format were aligned to the UCSC mouse reference genome (mm10) using TOPHAT21 (58) . Differentially expressed genes were identified using DESeq2, version 1.62. Only genes with a minimum log 2 fold change of ±2, a maximum Benjamini-Hochberg corrected P value of 0.05, and a minimum combined mean of 5 reads were classified as having significant differential expression. Gene set enrichment analysis (GSEA) software was used to perform GSEA against the GSEA database (59). DAVID/EASE software (https://david.ncifcrf.gov/summary.jsp) was used to establish whether specific cell functions and biologic processes, defined according to gene ontology, were significantly represented among the deregulated genes. Data were also analyzed with Ingenuity Pathway Analysis (IPA) software (QIAGEN) (see Supplemental Tables 2-4) .
Isolation of immune cells. BM cells were isolated from the tibia and femur and cultured in RPMI 1640 medium with 10% FBS, 1% penicillinstreptomycin, and 55 mM β-mercaptoethanol. For BM-derived macrophages (BMDMs), BM cells were cultured in 10% L929 conditioned media containing macrophage-colony stimulating factor (M-CSF) for 5 days. For BM-derived cDCs, BM cells were cultured in the presence of 20 ng/mL murine GM-CSF and 10 ng/ml IL-4 for 6-8 days. Peritoneal macrophages were obtained by injecting mice i.p. with 3 ml 4% (v/v) thioglycollate (BD), and peritoneal cavities were flushed after 3 days with RPMI 1640 media with 2% FBS. Mouse CD4 cells were isolated from SP or LN by using the Dynabeads Untouched Mouse CD4 Cells Kit (Thermo Fisher). 10 8 cells/mL of splenocytes and LN cells were blocked with heat-inactivated FBS and antibody mix against CD8, B220, CD11b, Ter-119, and CD16/32. After 20 minutes incubation at 4°C, cells were washed with isolation buffer (PBS [Ca 2+ and Mg 2+ free] supplemented with 0.1% BSA and 2 mM EDTA) and incubated with prewashed mouse depletion Dynabeads for 15 minutes at room temperature (RT). Beadbound cells were resuspended by gently pipetting and were placed in the magnet for 2 minutes. Untouched CD4 + T cells in the supernatant were then collected. Similarly, total B cells were isolated from the tumor, LN, SP, or BM using mouse CD45R (B220) microbeads (Miltenyi Biotec) or PE-positive selection beads with PE-B220 antibody. In some experiments, B cells were pretreated with 1 μg/mL CD40L (Thermo Fisher, catalog 34-8512-80), or anti-CD40 (CD40 agonist) (Thermo Fisher, clone HM40-3, catalog 14-0402-82), 10 ng/mL IL-4 (Thermo Fisher, catalog PMC0045), 100 ng/mL LPS (Sigma-Aldrich, catalog L4391), specific inhibitor of JNK (Sigma-Aldrich, catalog S5567, SP 600125, 5 μmol/L), ERK (Sigma-Aldrich, catalog 19-147, U0126, 20 μmol/L), NF-κB (Sigma-Aldrich, catalog B5556, BAY 11-7082, 5 μmol/L), p38 (Sigma-Aldrich, catalog S8307, SB 203580, 20 μmol/L), and STAT3 (Sigma-Aldrich, catalog 573097, WP1066, 5 μmol/L). Peripheral neutrophils were obtained from the peritoneal cavity by i.p. injection of mice with 2 ml 4% (v/v) thioglycollate for 4 hours, followed by the collection of peritoneal exudates with RPMI 1640 media with 2% FBS. Neutrophils were then purified by sorting Ly6G + CD11b + cells or using EasySep jci.org Volume 129 Number 12 December 2019
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